[Trial therapy with 3,4,5 trimethoxybenzoyl-epsilon-aminocaproic acid in acute myocardial infarct].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000404:Ajmaline / Q000627:therapeutic use; D000614:Aminocaproates / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology; D002986:Clinical Trials as Topic; D005260:Female; D006321:Heart; D006327:Heart Block / Q000209:etiology; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012421:Rupture; D012770:Shock, Cardiogenic / Q000209:etiology
D000614:Aminocaproates; D000404:Ajmaline
Esperienza di terapia con acido 3,4,5 trimetossibenzoik-epsilon-aminocaproico nell'infarto miocardico acuto.